G2 Investment Partners Management’s Tandem Diabetes Care TNDM Stock Holding History

G2 Investment Partners Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-19,754	Closed	-$1.95M	–	95
2020 Q2	$1.95M	Buy	+19,754	New	+$1.58M	0.46%	55
2020 Q1	–	Sell	-8,671	Closed	-$517K	–	102
2019 Q4	$517K	Sell	8,671 -9,605	-53%	-$592K	0.17%	73
2019 Q3	$1.08M	Sell	18,276 -2,915	-14%	-$186K	0.31%	55
2019 Q2	$1.37M	Buy	+21,191	New	+$1.37M	0.43%	47
2019 Q1	–	Sell	-39,900	Closed	-$1.51M	–	72
2018 Q4	$1.51M	Buy	+39,900	New	+$1.41M	0.63%	39

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

G2 Investment Partners Management's TNDM Position: Q3 2020 in Review

G2 Investment Partners Management sold out of Tandem Diabetes Care (TNDM) in Q3 2020, closing a stake of 19,754 shares — an estimated $1.95M sold.

G2 Investment Partners Management first reported a position in TNDM in Q4 2018 and held it in 5 quarters. The position peaked at $1.95M in Q2 2020. 321 funds tracked by Wall St. Rank hold TNDM as of Q3 2020.

G2 Investment Partners Management reported no remaining Tandem Diabetes Care position as of Q3 2020 after selling out during the quarter.
G2 Investment Partners Management sold 19,754 Tandem Diabetes Care shares in Q3 2020, an estimated $1.95M.
G2 Investment Partners Management first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 5 quarters.
G2 Investment Partners Management's Tandem Diabetes Care position peaked at $1.95M in Q2 2020.
321 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2020.

Based on G2 Investment Partners Management's 13F filing for Q3 2020, filed 16 Nov 2020.